Insider Transactions in Q2 2021 at Vir Biotechnology, Inc. (VIR)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 07
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
4,180
+25.03%
|
-
|
|
Apr 07
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-1.81%
|
-
|
|
Apr 07
2021
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
5,989
+25.0%
|
-
|
|
Apr 07
2021
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-1.81%
|
-
|
|
Apr 01
2021
|
Jay Parrish Chief Business Officer |
SELL
Open market or private sale
|
Direct |
6,944
-42.85%
|
$354,144
$51.4 P/Share
|
|
Apr 01
2021
|
Jay Parrish Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,944
+18.75%
|
$6,944
$1.53 P/Share
|
|
Apr 01
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
4,176
+33.34%
|
-
|
|
Apr 01
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-1.78%
|
-
|
|
Apr 01
2021
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
5,987
+33.33%
|
-
|
|
Apr 01
2021
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-1.78%
|
-
|